7
Research
One of our ongoing aims is to improve the quality of our services for patients. We are committed to the highest level of research in dermatology. Our achievements in this field – as judged by the cumulative impact factors for 2019 and 2020 (1,082 and 1,000) – position us among the world’s leading departments. Our research activities focus primarily on basic, patient-oriented translational and clinical research in dermato-oncology, where we concentrate on the pathogenesis, early diagnosis and targeted treatment of skin cancer, particularly in melanoma, cutaneous lymphoma and non-melanoma skin cancers. Immunodermatology is also a research focus, in particular innate immunity and T-cell biology in inflammatory skin diseases, notably psoriasis, neutrophilic dermatoses, cutaneous drug eruptions and severe allergic adverse drug reactions. Allergy research is centered on atopic dermatitis, drug and food allergies, and immunotherapy.
The aim of our research activities is to: – – – –
promote high-quality research with clinical relevance in the defined fields of focus promote intensive networking and collaboration with other institutes and departments at the University of Zurich and ETH, and through active participation in networks such as Cancer Network Zurich and Life Science Zurich support fellowships abroad in excellent research institutions and maximize competitive research funding, including from the Swiss National Science Foundation (SNF professorships) create endowed professorships in our department for inflammatory skin disease, skin cancer and allergy, with the aim of recruiting and retaining leaders in these r esearch fields.
Impact Factor Publications 2004–2020
18
